Skip to main content
SpringerLink
Log in

Single-Fraction HDR Boost

  • Chapter
  • First Online:
Brachytherapy

  • 808 Accesses

Abstract

In this chapter, the authors are going to describe the reason why we propose to administer the boost with a single dose of HDR brachytherapy: first, it is an excellent way to escalate the dose, and second it is a very accurate and sure method.

We are going to comment about different authors that are using single-dose boost or several fraction boost and the advantages and withdrawals of both. The main advantage is that we only need one surgical procedure for needle insertion, and thus movement between fractions can be avoided. And it can be done in real-time administering the brachytherapy in the operating theatre.

We are going to discuss about dose equivalence to normofractionation using alpha-beta model. And last, we are going to describe our technique in detail and our institution’s result.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Martinez AA, Gustafson G, Gonzalez J, et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53(2):316–27.

    Article  PubMed  Google Scholar 

  2. Vargas CE, Martinez AA, al BTP e. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study. Int J Radiat Oncol Biol Phys. 2006;66(2):416–23.

    Article  PubMed  Google Scholar 

  3. Al-Mamgani A, van Putten WLJ, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–8.

    Article  PubMed  Google Scholar 

  4. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8:475–87.

    Article  PubMed  Google Scholar 

  5. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67–74.

    Article  PubMed  Google Scholar 

  6. Peeters STH, Heemsbergen WD, van Putten WLJ, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005;61:1019–34.

    Article  PubMed  Google Scholar 

  7. Pistis F, Guedea F, Pera J, et al. External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology. Brachytherapy. 2010;9(1):15–22.

    Article  PubMed  Google Scholar 

  8. Boladeras A, Santorsa L, Gutierrez C, et al. External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer. Radiother Oncol. 2014;112(2):227–32.

    Article  PubMed  Google Scholar 

  9. Hoskin PJ, Rojas AM, Bownes PJ, et al. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol. 2012;103:217–22.

    Article  PubMed  Google Scholar 

  10. Agoston P, Major T, Fröhlich G, et al. Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. Brachytherapy. 2011;10:376–84.

    Article  PubMed  Google Scholar 

  11. Galalae RM, Martinez A, Nuernberg N, et al. Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups? Strahlenther Onkol. 2006;182:135–41.

    Article  PubMed  Google Scholar 

  12. Galalae RM, Zakikhany NH, Geiger F, et al. The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer-a benchmark for high-tech external beam radiotherapy alone? Brachytherapy. 2014;13:117–22.

    Article  PubMed  Google Scholar 

  13. Hoskin PJ, Colombo A, Henry A, et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update. Radiother Oncol. 2013;107(3):325–32. https://doi.org/10.1016/j.radonc.2013.05.002.

    Article  PubMed  Google Scholar 

  14. Vigneault E, Mbodji K, Magnan S, et al. High-dose-rate brachytherapy boost for prostate cancer treatment: different combinations of hypofractionated regimens and clinical outcomes. Radiother Oncol. 2017;124(1):49–55. https://doi.org/10.1016/j.radonc.2017.06.012.

    Article  PubMed  Google Scholar 

  15. Martinez AA, Gonzalez J, Ye H, et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:363–70.

    Article  PubMed  Google Scholar 

  16. Yamada Y, Bhatia S, Zaider M, et al. Favorable clinical outcomes of three dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy. 2006;5:157–64.

    Article  PubMed  Google Scholar 

  17. Morton G, Loblaw A, Cheung P, et al. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? Radiother Oncol. 2011;100:463–7.

    Article  PubMed  Google Scholar 

  18. Hoskin PJ, Bownes PJ, Ostler P, et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol. 2003;68:285–8.

    Article  PubMed  Google Scholar 

  19. Reynés-Llompart G, Pino F, Modolell I, Gullón C, et al. Impact of prostate catheter displacement in inverse planning--simulated annealing and geometric optimization. Brachytherapy. 2016;15(1):112–7. https://doi.org/10.1016/j.brachy.2015.10.003.

    Article  PubMed  Google Scholar 

  20. Aitkenhead AR. Injuries associated with anaesthesia. A global perspective. Br J Anaesth. 2005;95:95–109.

    Article  CAS  PubMed  Google Scholar 

  21. Fatyga M, Williamson JF, Dogan N, et al. A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study. Med Phys. 2009;36:3995–4006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Proust-Lima C, Taylor JMG, Sécher S, et al. Confirmation of a low a/b ratio for prostate cancer treated by external beam radiation therapy alone using a posttreatment repeated-measures model for PSA dynamics. Int J Radiat Oncol Biol Phys. 2011;79:195–201.

    Article  PubMed  Google Scholar 

  23. Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:507–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Institut Català d’Oncologia, L’Hospitalet, Barcelona, Spain

    Cristina Gutiérrez, Andrea Slocker, Dina Najjari, Ferran Ferrer, Anna Boladeras & Ferran Guedea

  2. Department of Medical Physics and Radiation Protection, Institut Català d’Oncologia, L’Hospitalet, Barcelona, Spain

    Ignasi Modolell

  3. Department of Urology, Hospital Universitari de Bellvitge, L’Hospitalet, Barcelona, Spain

    Jose Francisco Suárez

Authors
  1. Cristina Gutiérrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Slocker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina Najjari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ignasi Modolell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ferran Ferrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Boladeras
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jose Francisco Suárez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ferran Guedea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Gutiérrez .

Editor information

Editors and Affiliations

  1. Radiation Oncology Department, The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

    Yasuo Yoshioka

  2. Department of Radiation Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

    Jun Itami

  3. Radiation Oncology Department, The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

    Masahiko Oguchi

  4. Department of Radiation Oncology, Gunma University, Maebashi, Gunma, Japan

    Takashi Nakano

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gutiérrez, C. et al. (2019). Single-Fraction HDR Boost. In: Yoshioka, Y., Itami, J., Oguchi, M., Nakano, T. (eds) Brachytherapy. Springer, Singapore. https://doi.org/10.1007/978-981-13-0490-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-0490-3_14

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-0489-7

  • Online ISBN: 978-981-13-0490-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation